• TMRE Assay: Reading Mitochondrial Stress in NECSO

  2026-09-23

  The TMRE mitochondrial membrane potential assay kit can reveal mitochondrial depolarization during sodium-overload stress, but fluorescence alone cannot identify the cause or type of cell death. This article connects TMRE measurements to recent NECSO findings and shows how to design more interpretable experiments.

• 5-Aminolevulinic Acid HCl in Infection Biology

  2026-09-23

  5-Aminolevulinic acid HCl provides a precise way to interrogate tetrapyrrole flux beyond gene deletion alone. This article translates a Salmonella haem study into a causal assay framework while distinguishing infection biology from porphyrin-based cancer research.

• BACE Inhibition, Aβ Reduction, and Synaptic Function

  2026-09-22

  Satir et al. showed that partial β-secretase inhibition can reduce amyloid-β secretion without immediately impairing synaptic transmission in cultured primary cortical neurons. The study separates potentially protective, moderate BACE inhibition from higher exposures associated with synaptic dysfunction, offering a useful framework for interpreting dose and target engagement in Alzheimer’s disease research.

• Patient-Derived Gastric Cancer Assembloids Explained

  2026-09-22

  Shapira-Netanelov and colleagues developed a patient-derived gastric cancer assembloid that combines matched tumor organoids with stromal cell subpopulations from the same tumor. The model revealed that stromal composition reshapes gene expression and drug sensitivity, providing a more physiologically relevant platform for resistance studies and personalized treatment evaluation.

• L-Ornithine as a Precision Probe of Nitrogen Flux

  2026-09-21

  L-Ornithine is more than a urea cycle intermediate: it can be used to distinguish impaired nitrogen disposal from downstream liver–brain signaling. This guide translates recent OTC–ornithine research into practical assay design, controls, and interpretation strategies.

• Triazole ALDH2 Activators for Myocardial Ischemia

  2026-09-21

  A 2025 ACS Medicinal Chemistry Letters study used molecular simulation and structural optimization to identify triazole-based ALDH2 activators with improved activity and water solubility. Lead compound Z17 produced the strongest reported ALDH2 activation in the study and improved cardiac function, infarct burden, and injury biomarkers in a mouse ischemia–reperfusion model.

• Trypsin-Responsive Nanomedicine for Acute Pancreatitis

  2026-09-20

  This ACS Nano study introduces a mesoporous organosilica nanomedicine that combines pancreatic acinar cell targeting with trypsin-triggered release of the calcium chelator BAPTA-AM. In a mouse model of acute pancreatitis, the formulation reduced intracellular calcium overload, suppressed inflammatory and necrotic signaling, improved pancreatic biomarkers, and increased survival, while remaining a preclinical platform requiring further translational validation.

• 5-hme-dCTP for 5hmC Assay Design

  2026-09-19

  Learn how 5-hme-dCTP supports calibrated 5hmC assay development without being mistaken for a direct endogenous 5hmC detector. This guide connects nucleotide chemistry, polymerase behavior, and rice drought-response epigenetics to better experimental decisions.

• Bestatin (Ubenimex): Workflows for Protease Research

  2026-09-18

  Bestatin (Ubenimex) provides a selective way to connect aminopeptidase activity with MDR, apoptosis, and inflammatory cell-death phenotypes. This practical guide covers stock preparation, dose selection, assay controls, reference-study translation, and troubleshooting for reproducible experiments.

• PDHA1 Succinylation in Cholangiocarcinoma Immune Escape

  2026-09-18

  A 2025 Nature Communications study identifies PDHA1 K83 succinylation as a metabolic control point linking cholangiocarcinoma metabolism to macrophage immune suppression. The work shows that α-ketoglutarate accumulation activates macrophage OXGR1–MAPK signaling, reduces MHC-II antigen presentation, and that inhibiting succinylation with CPI-613 can improve gemcitabine–cisplatin activity in preclinical models.

• Bestatin (Ubenimex) Experimental Workflows

  2026-09-17

  Bestatin (Ubenimex) combines selective aminopeptidase inhibition with a useful chemical-genetics phenotype in plant jasmonate signaling. This guide translates that evidence into practical workflows for aminopeptidase activity measurement, multidrug resistance (MDR) research, apoptosis assay design, and Arabidopsis screening.

• Minocycline HCl in Retinal Microglia Workflows

  2026-09-17

  Minocycline HCl provides a practical pharmacological perturbation for testing whether microglial activity contributes to retinal amyloid clearance. This guide translates 40-Hz flicker findings into controlled preparation, dosing, endpoint selection, and troubleshooting strategies for inflammation and neuroprotection studies.

• Bay 11-7821: NF-κB Assay Workflow Guide

  2026-09-16

  Bay 11-7821, also called BAY 11-7082, provides a practical downstream perturbation point for separating NF-κB-dependent inflammation from lactate-driven macrophage responses. This workflow guide covers dose finding, reporter and protein readouts, exosomal HMGB1 experiments, apoptosis applications, and troubleshooting of solubility and cytotoxicity artifacts.

• EZ Cap™ Mouse CD80 mRNA (m1Ψ, HA tag): Assay Design

  2026-09-16

  EZ Cap™ Mouse CD80 mRNA (m1Ψ, HA tag) enables a controlled way to study mouse CD80-mediated T-cell co-stimulation. This guide translates published tumor-vaccine findings into practical assay design, controls, readouts, and interpretation strategies.

• Necrostatin-1 and RIP1: A Translational Lens

  2026-09-15

  A mechanism-first guide to using Necrostatin-1 as a RIP1 kinase inhibitor in necroptosis assays and translational injury models, with a strategic framework connecting microbial virulence, Crohn’s disease biology, and host-cell death without overstating the evidence.

7944 records 1/530 page Next 12345 下5页 Last page